EUVIMEDEUVIMED entdecken
Crossref

The dual role of P2RY12: impact of polymorphism and expression on ischemic events and bleeding in patients with ST-segment elevation myocardial infarction receiving antithrombotic therapy

Jiqing Li, Zheng Gong, Shikun Wang, Jianhua Gu, Shuo Wu, Jiaojiao Pang, Yuguo Chen

Journal of Thrombosis and Haemostasis · 2026-07 · 24 (7) · 2614-2626

DOI: 10.1016/j.jtha.2026.03.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-07. Verfasst von Jiqing Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China; Shandong Provincial Clinical Research Center for Emergency and …. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Receptors, Purinergic P2Y12, Hemorrhage, Ticagrelor. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Key Technology Research and Development Program of Shandong Province, Natural Science Foundation of Shandong Province, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The influence of P2RY12 polymorphisms and expression on the ischemia-bleeding balance in patients with ST-segment elevation myocardial infarction (STEMI) remains poorly defined. OBJECTIVES: To evaluate the associations of P2RY12 with major adverse cardiovascular events (MACE) and bleeding risk in STEMI patients treated with ticagrelor. METHODS: This prospective cohort study enrolled patients with STEMI who underwent percutaneous coronary intervention and received ticagrelor therapy between 2018 and 2020. The main outcomes were MACEs and bleeding events within 2 years. A Cox model was used to examine the effects of P2RY12 polymorphisms on both events. Additionally, the P2RY12 expression scores were constructed to further evaluate the association between its expression levels and both events. RESULTS: A total of 1828 STEMI patients were included, with 194 MACE (10.61%) and 237 bleeding events (12.96%) recorded. Compared with the rs10755105 C/C, the MACE hazard ratios (HRs) (95% CI) of T/C and T/T carriers were 0.57 (0.42-0.79) and 0.67 (0.45-1.00), respectively, while for bleeding, they were 1.35 (0.99-1.85) and 1.53 (1.06-2.20), respectively. P2RY12 expression scores showed a U-shaped relationship with MACE risk and an inverse U-shaped association with bleeding (Pnonlinear < .05). Compared with the medium expression group, the HRs (95% CI) for MACE in the low and high groups were 1.84 (1.28-2.66) and 1.40 (0.83-2.34), respectively, and for bleeding were 0.77 (0.58-1.01) and 0.53 (0.33-0.85), respectively. CONCLUSION: Both rs10755105 and the P2RY12 expression score show opposing effects on ischemic and bleeding risks. The identified non-linear relationships provide novel insights for refined risk stratification in STEMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ST Elevation Myocardial InfarctionReceptors, Purinergic P2Y12HemorrhageTicagrelorPlatelet Aggregation InhibitorsPolymorphism, Single NucleotideFibrinolytic AgentsHumansMaleFemaleProspective StudiesPercutaneous Coronary InterventionMiddle AgedRisk FactorsAgedTreatment OutcomeRisk AssessmentTime FactorsGenetic Predisposition to Disease

Stichwörter der Autor:innen

BleedingMACEP2RY12STEMITicagrelor

Substanzen

Receptors, Purinergic P2Y12P2RY12 protein, humanTicagrelorPlatelet Aggregation InhibitorsFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Emergency Medicine, Qilu Hospital of Shandong University, Jinan, China; Shandong Provincial Clinical Research Center for Emergency and Critical Care Medicine, Institute of Emergency and Critical Care Medic…

Förderung

  • Key Technology Research and Development Program of Shandong Province
  • Natural Science Foundation of Shandong Province
  • China Postdoctoral Science Foundation
  • Shandong University Qilu Hospital
  • National Key Research and Development Program of China
  • Shandong University

Zitieren

APA

Li, J., Gong, Z., Wang, S., Gu, J., Wu, S., Pang, J., & Chen, Y. (2026). The dual role of P2RY12: impact of polymorphism and expression on ischemic events and bleeding in patients with ST-segment elevation myocardial infarction receiving antithrombotic therapy. Journal of Thrombosis and Haemostasis, 24(7), 2614-2626. https://doi.org/10.1016/j.jtha.2026.03.016

Vancouver

Li J, Gong Z, Wang S, Gu J, Wu S, Pang J, et al. The dual role of P2RY12: impact of polymorphism and expression on ischemic events and bleeding in patients with ST-segment elevation myocardial infarction receiving antithrombotic therapy. Journal of Thrombosis and Haemostasis. 2026;24(7):2614-2626. doi:10.1016/j.jtha.2026.03.016

BibTeX
@article{Li2026,
  author = {Li, Jiqing and Gong, Zheng and Wang, Shikun and Gu, Jianhua and Wu, Shuo and Pang, Jiaojiao and Chen, Yuguo},
  title = {The dual role of P2RY12: impact of polymorphism and expression on ischemic events and bleeding in patients with ST-segment elevation myocardial infarction receiving antithrombotic therapy},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  volume = {24},
  number = {7},
  pages = {2614--2626},
  doi = {10.1016/j.jtha.2026.03.016}
}
Kostenlos starten →